Retrospective Assessment of the Risk of Peripartum Hemorrhage in Pregnant Women : Retrospective Assessment of the Diagnostic Performance of the HEMSTOP Standardized Questionnaire
Sponsored by Brugmann University Hospital
About this trial
Last updated 3 years ago
Study ID
CHUB-MAT-HEMSTOP
Status
Completed
Type
Observational
Placebo
No
Accepting
18+ Years
Female
Trial Timing
Ended 3 years ago
What is this trial about?
The diagnostic performance of the HEMSTOP (Hematoma, hEmorrhage, Menorrhagia, Surgery, Tooth
extraction, Obstetrics, Parents) standardized questionnaire collected during the preoperative
anesthesia consultation in order to detect a deficit in hemostasis associated with the risk
of hemorrhage in pregnant women will be analyzed. The primary aim of the study is to assess
the sensitivity and the specificity of the HEMSTOP questionnaire to identity patients with an
abnormal first-line hemostasis test requiring further development by performing second-line
hemostasis tests. The second aim of the study is to assess the sensitivity and specificity of
the HEMSTOP questionnaire in predicting postpartum hemorrhage.
What are the participation requirements?
Inclusion Criteria